Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Radius Health (RDUS)

Radius Health (RDUS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 900,354
  • Shares Outstanding, K 46,172
  • Annual Sales, $ 99,240 K
  • Annual Income, $ -221,340 K
  • 60-Month Beta 0.72
  • Price/Sales 5.88
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.76
  • Number of Estimates 5
  • High Estimate -0.54
  • Low Estimate -1.09
  • Prior Year -0.90
  • Growth Rate Est. (year over year) +15.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.23 +6.03%
on 01/13/20
21.75 -11.13%
on 12/26/19
-2.00 (-9.38%)
since 12/20/19
3-Month
18.23 +6.03%
on 01/13/20
29.89 -35.33%
on 11/04/19
-7.80 (-28.75%)
since 10/22/19
52-Week
16.24 +19.03%
on 01/23/19
29.97 -35.50%
on 09/17/19
+2.66 (+15.96%)
since 01/22/19

Most Recent Stories

More News
Moving Average Crossover Alert: Radius Health

Radius Health, Inc. (RDUS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

RDUS : 19.17 (-1.69%)
Radius Health In Has Returned 16.3% Since SmarTrend Recommendation (RDUS)

SmarTrend identified a Downtrend for Radius Health In (NASDAQ:RDUS) on November 6th, 2019 at $23.60. In approximately 2 months, Radius Health In has returned 16.27% as of today's recent price of $19.76....

RDUS : 19.17 (-1.69%)
Radius Exceeds 2019 Financial Guidance and Provides Business Update at the 38th Annual J.P. Morgan Healthcare Conference

Full-Year 2019 TYMLOS U.S. net revenue exceeds financial guidance, surpassing $172M.

JPM : 136.66 (-0.13%)
RDUS : 19.17 (-1.69%)
Radius Health to Present at the 38th Annual J.P. Morgan Healthcare Conference

Radius Health, Inc. (Nasdaq: RDUS), today announced that its senior executive management team will present a corporate update at the 38 Annual J.P. Morgan Healthcare Conference on Tuesday, January 14,...

JPM : 136.66 (-0.13%)
RDUS : 19.17 (-1.69%)
Radius Health Is in Oversold Territory: What???s Next?

Radius Health has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

RDUS : 19.17 (-1.69%)
Radius Health In Set to Possibly Rebound After Yesterday's Selloff of 1.44%

Radius Health In (NASDAQ:RDUS) traded in a range yesterday that spanned from a low of $19.72 to a high of $20.23. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

RDUS : 19.17 (-1.69%)
Shares of RDUS Down 12.3% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Radius Health In (NASDAQ:RDUS) on November 6th, 2019 at $23.60. In approximately 2 months, Radius Health In has returned 12.33% as of today's recent price of $20.69....

RDUS : 19.17 (-1.69%)
SmarTrend Watching for Potential Rebound in Shares of Radius Health In After 1.28% Loss

Radius Health In (NASDAQ:RDUS) traded in a range yesterday that spanned from a low of $20.58 to a high of $21.07. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of...

RDUS : 19.17 (-1.69%)
After Yesterday's Decline of 4.26%, Radius Health In Offers Investors Better Value

Radius Health In (NASDAQ:RDUS) traded in a range yesterday that spanned from a low of $21.43 to a high of $22.72. Yesterday, the shares fell 4.3%, which took the trading range below the 3-day low of...

RDUS : 19.17 (-1.69%)
Amgen's Osteoporosis Drug Evenity Gets Approval in Europe

The EC grants marketing authorization to Amgen (AMGN) and partner UCB's Evenity for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture.

ANIK : 45.47 (-0.92%)
ALKS : 18.62 (+0.54%)
AMGN : 236.51 (-0.46%)
RDUS : 19.17 (-1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Trade RDUS with:

Business Summary

Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both...

See More

Key Turning Points

2nd Resistance Point 20.19
1st Resistance Point 19.85
Last Price 19.17
1st Support Level 19.26
2nd Support Level 19.01

See More

52-Week High 29.97
Fibonacci 61.8% 24.73
Fibonacci 50% 23.10
Fibonacci 38.2% 21.48
Last Price 19.17
52-Week Low 16.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar